Page last updated: 2024-08-24

lercanidipine and alloxan

lercanidipine has been researched along with alloxan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendhack, LM; Castro, MM; Fernandes, K; Gerlach, RF; Martinez, ML; Rizzi, E; Tanus-Santos, JE	1

Other Studies

1 other study(ies) available for lercanidipine and alloxan

Article	Year
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European journal of pharmacology, 2008, Dec-03, Volume: 599, Issue:1-3 Topics: Alloxan; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Blood Pressure; Diabetes Mellitus, Experimental; Dihydropyridines; Enzyme Precursors; Fluorometry; Gelatinases; Gene Expression Regulation, Enzymologic; Male; Matrix Metalloproteinase 2; Oxidative Stress; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Tissue Inhibitor of Metalloproteinase-2	2008

Article

Year

Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.

European journal of pharmacology, 2008, Dec-03, Volume: 599, Issue:1-3

Topics: Alloxan; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Blood Pressure; Diabetes Mellitus, Experimental; Dihydropyridines; Enzyme Precursors; Fluorometry; Gelatinases; Gene Expression Regulation, Enzymologic; Male; Matrix Metalloproteinase 2; Oxidative Stress; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Tissue Inhibitor of Metalloproteinase-2

2008